An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer

Chung Wei Fan, Hong Arh Fan, Soon Hwei Hsu, Chang Chuan Chan, Shih Yuan Chen, Yuan Hsun Hsu, Err Cheng Chan

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The goal of this study was to develop a simple and rapid in vitro drug resistance assay to ascertain the effectiveness of 5-fluorouracil (5-FU) for the individual therapy of colorectal cancer. Colorectal cancer cells were isolated from tumor specimens and, after 4 h exposure to high doses of 5-FU cell viability was measured with an ATP assay. The average IC 50 concentration for 5-FU was calculated as 4000 μg/ml from 35 patients' tumors. The tumor cells were defined as extreme drug resistance with a survival rate 1 standard deviation (SD) over IC 50, low drug resistance (LDR) with a survival rate 1 SD below IC 50, and intermediate drug resistance (IDR) with survival rate between these two. The drug resistant assay for 102 patients' cancer cells showed that the proportion of patients with LDR to 5-fluorouracil was 19%. The in vitro drug resistance of the cancer cells was not correlated with cancer stages or by patient sex or age. However, most mucinous and poor differentiated cancer cells showed extreme or IDR. The in vitro ATP assay values for 25 Duke's D patients receiving postoperative 5-FU chemotherapy were comparable with clinical postchemotherapy responses. The sensitivity and specificity of the assay were 100 and 95%, respectively. This short time-high dose drug exposure assay may serve as an aid to improve 5-FU treatment for individual chemotherapy.

Original languageEnglish
Pages (from-to)181-188
Number of pages8
JournalCancer Letters
Volume214
Issue number2
DOIs
Publication statusPublished - Oct 28 2004

Fingerprint

Drug Resistance
Fluorouracil
Colorectal Neoplasms
Pharmaceutical Preparations
Neoplasms
Survival Rate
Adenosine Triphosphate
Drug Therapy
In Vitro Techniques
Cell Survival
Sensitivity and Specificity
Therapeutics

Keywords

  • 5-Fluorouracil
  • ATP assay
  • Chemotherapy
  • Extreme drug resistance

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Fan, C. W., Fan, H. A., Hsu, S. H., Chan, C. C., Chen, S. Y., Hsu, Y. H., & Chan, E. C. (2004). An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer. Cancer Letters, 214(2), 181-188. https://doi.org/10.1016/j.canlet.2004.06.004

An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer. / Fan, Chung Wei; Fan, Hong Arh; Hsu, Soon Hwei; Chan, Chang Chuan; Chen, Shih Yuan; Hsu, Yuan Hsun; Chan, Err Cheng.

In: Cancer Letters, Vol. 214, No. 2, 28.10.2004, p. 181-188.

Research output: Contribution to journalArticle

Fan, CW, Fan, HA, Hsu, SH, Chan, CC, Chen, SY, Hsu, YH & Chan, EC 2004, 'An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer', Cancer Letters, vol. 214, no. 2, pp. 181-188. https://doi.org/10.1016/j.canlet.2004.06.004
Fan, Chung Wei ; Fan, Hong Arh ; Hsu, Soon Hwei ; Chan, Chang Chuan ; Chen, Shih Yuan ; Hsu, Yuan Hsun ; Chan, Err Cheng. / An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer. In: Cancer Letters. 2004 ; Vol. 214, No. 2. pp. 181-188.
@article{64ebb5e564da49fb80cace5959d375cf,
title = "An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer",
abstract = "The goal of this study was to develop a simple and rapid in vitro drug resistance assay to ascertain the effectiveness of 5-fluorouracil (5-FU) for the individual therapy of colorectal cancer. Colorectal cancer cells were isolated from tumor specimens and, after 4 h exposure to high doses of 5-FU cell viability was measured with an ATP assay. The average IC 50 concentration for 5-FU was calculated as 4000 μg/ml from 35 patients' tumors. The tumor cells were defined as extreme drug resistance with a survival rate 1 standard deviation (SD) over IC 50, low drug resistance (LDR) with a survival rate 1 SD below IC 50, and intermediate drug resistance (IDR) with survival rate between these two. The drug resistant assay for 102 patients' cancer cells showed that the proportion of patients with LDR to 5-fluorouracil was 19{\%}. The in vitro drug resistance of the cancer cells was not correlated with cancer stages or by patient sex or age. However, most mucinous and poor differentiated cancer cells showed extreme or IDR. The in vitro ATP assay values for 25 Duke's D patients receiving postoperative 5-FU chemotherapy were comparable with clinical postchemotherapy responses. The sensitivity and specificity of the assay were 100 and 95{\%}, respectively. This short time-high dose drug exposure assay may serve as an aid to improve 5-FU treatment for individual chemotherapy.",
keywords = "5-Fluorouracil, ATP assay, Chemotherapy, Extreme drug resistance",
author = "Fan, {Chung Wei} and Fan, {Hong Arh} and Hsu, {Soon Hwei} and Chan, {Chang Chuan} and Chen, {Shih Yuan} and Hsu, {Yuan Hsun} and Chan, {Err Cheng}",
year = "2004",
month = "10",
day = "28",
doi = "10.1016/j.canlet.2004.06.004",
language = "English",
volume = "214",
pages = "181--188",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer

AU - Fan, Chung Wei

AU - Fan, Hong Arh

AU - Hsu, Soon Hwei

AU - Chan, Chang Chuan

AU - Chen, Shih Yuan

AU - Hsu, Yuan Hsun

AU - Chan, Err Cheng

PY - 2004/10/28

Y1 - 2004/10/28

N2 - The goal of this study was to develop a simple and rapid in vitro drug resistance assay to ascertain the effectiveness of 5-fluorouracil (5-FU) for the individual therapy of colorectal cancer. Colorectal cancer cells were isolated from tumor specimens and, after 4 h exposure to high doses of 5-FU cell viability was measured with an ATP assay. The average IC 50 concentration for 5-FU was calculated as 4000 μg/ml from 35 patients' tumors. The tumor cells were defined as extreme drug resistance with a survival rate 1 standard deviation (SD) over IC 50, low drug resistance (LDR) with a survival rate 1 SD below IC 50, and intermediate drug resistance (IDR) with survival rate between these two. The drug resistant assay for 102 patients' cancer cells showed that the proportion of patients with LDR to 5-fluorouracil was 19%. The in vitro drug resistance of the cancer cells was not correlated with cancer stages or by patient sex or age. However, most mucinous and poor differentiated cancer cells showed extreme or IDR. The in vitro ATP assay values for 25 Duke's D patients receiving postoperative 5-FU chemotherapy were comparable with clinical postchemotherapy responses. The sensitivity and specificity of the assay were 100 and 95%, respectively. This short time-high dose drug exposure assay may serve as an aid to improve 5-FU treatment for individual chemotherapy.

AB - The goal of this study was to develop a simple and rapid in vitro drug resistance assay to ascertain the effectiveness of 5-fluorouracil (5-FU) for the individual therapy of colorectal cancer. Colorectal cancer cells were isolated from tumor specimens and, after 4 h exposure to high doses of 5-FU cell viability was measured with an ATP assay. The average IC 50 concentration for 5-FU was calculated as 4000 μg/ml from 35 patients' tumors. The tumor cells were defined as extreme drug resistance with a survival rate 1 standard deviation (SD) over IC 50, low drug resistance (LDR) with a survival rate 1 SD below IC 50, and intermediate drug resistance (IDR) with survival rate between these two. The drug resistant assay for 102 patients' cancer cells showed that the proportion of patients with LDR to 5-fluorouracil was 19%. The in vitro drug resistance of the cancer cells was not correlated with cancer stages or by patient sex or age. However, most mucinous and poor differentiated cancer cells showed extreme or IDR. The in vitro ATP assay values for 25 Duke's D patients receiving postoperative 5-FU chemotherapy were comparable with clinical postchemotherapy responses. The sensitivity and specificity of the assay were 100 and 95%, respectively. This short time-high dose drug exposure assay may serve as an aid to improve 5-FU treatment for individual chemotherapy.

KW - 5-Fluorouracil

KW - ATP assay

KW - Chemotherapy

KW - Extreme drug resistance

UR - http://www.scopus.com/inward/record.url?scp=4444312090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444312090&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2004.06.004

DO - 10.1016/j.canlet.2004.06.004

M3 - Article

VL - 214

SP - 181

EP - 188

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -